clarithromycin has been researched along with Bright Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McKenna, KE; Morris, TC; Ramadan, KM | 1 |
Krediet, RT; van Westrhenen, R; Weening, JJ | 1 |
2 other study(ies) available for clarithromycin and Bright Disease
Article | Year |
---|---|
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Clarithromycin; Dexamethasone; Diphosphonates; Glomerulonephritis; Humans; Idarubicin; Imidazoles; Immunosuppressive Agents; Male; Melphalan; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Pamidronate; Protein Synthesis Inhibitors; Pyrazines; Skin Neoplasms; Thalidomide; Zoledronic Acid | 2006 |
Pneumonia and glomerulonephritis caused by Mycoplasma pneumoniae.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Clarithromycin; Complement C3; Female; Glomerulonephritis; Humans; Kidney Glomerulus; Pneumonia; Pneumonia, Mycoplasma; Renal Dialysis | 1998 |